For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Opposing parties both claim a win from High Court decision
+Business
In print
Opposing parties both claim a win from High Court decision
Wednesday 24 July 2024, 03:20 PM

Valentia CEO Ahmad Javad [Image: Supplied]
Stephen Forbes investigates the latest developments in the ongoing legal battle between Valentia and Medtech
The two biggest players in New Zealand’s practice management system market are both claiming minor victories in their ongoing legal battle after the r
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.